Artal Group S.A. Ideaya Biosciences, Inc. Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
71.2MCall Options Held
29.8KPut Options Held
8.5K-
Black Rock Inc. New York, NY5.97MShares$201 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$164 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$140 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.05MShares$137 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$128 Million0.09% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.62B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...